{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:41:25Z","timestamp":1758638485309},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1038\/sj.tpj.6500179","type":"journal-article","created":{"date-parts":[[2003,8,20]],"date-time":"2003-08-20T19:25:35Z","timestamp":1061407535000},"page":"227-234","source":"Crossref","is-referenced-by-count":24,"title":["Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow"],"prefix":"10.1038","volume":"3","author":[{"given":"A","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W R","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Copolov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,8,20]]},"reference":[{"key":"BF6500179_CR1","first-page":"64","volume":"3","author":"HY Meltzer","year":"1995","unstructured":"Meltzer HY . Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci 1995; 3: 64\u201375.","journal-title":"Clin Neurosci"},{"key":"BF6500179_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/(SICI)1098-2396(199612)24:4<349::AID-SYN5>3.0.CO;2-D","volume":"24","author":"C Ashby Jr","year":"1996","unstructured":"Ashby Jr C, Wang R . Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 1996; 24: 349\u2013394.","journal-title":"Synapse"},{"key":"BF6500179_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/BF02245602","volume":"124","author":"B Kinon","year":"1996","unstructured":"Kinon B, Lieberman J . Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berl) 1996; 124: 2\u201334.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF6500179_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/schbul\/17.2.247","volume":"17","author":"AZ Safferman","year":"1991","unstructured":"Safferman AZ, Lieberman JA, Kane JM, Szymanski S, Kinon B . Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 1991; 17: 247\u2013261.","journal-title":"Schizophr Bull"},{"key":"BF6500179_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/oxfordjournals.schbul.a033333","volume":"24","author":"CR Young","year":"1998","unstructured":"Young CR, Bowers Jr MB, Mazure CM . Management of the adverse effects of clozapine. Schizophr Bull 1998; 24: 381\u2013390.","journal-title":"Schizophr Bull"},{"key":"BF6500179_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/0006-3223(94)90026-4","volume":"35","author":"T Rechlin","year":"1994","unstructured":"Rechlin T, Claus D, Weis M . Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine. Biol Psychiatry 1994; 35: 888\u2013892.","journal-title":"Biol Psychiatry"},{"key":"BF6500179_CR7","first-page":"298","volume":"152","author":"G Hayes","year":"1995","unstructured":"Hayes G, Gibler B . Clozapine-induced constipation (letter). Am J Psychiatry 1995; 152: 298.","journal-title":"Am J Psychiatry"},{"key":"BF6500179_CR8","first-page":"157","volume":"55","author":"DSG Umbritcht","year":"1994","unstructured":"Umbritcht DSG, Pollack S, Kane JM . Clozapine and weight gain. J Clin Psychiatry 1994; 55: 157\u2013160.","journal-title":"J Clin Psychiatry"},{"key":"BF6500179_CR9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5694\/j.1326-5377.1998.tb141414.x","volume":"168","author":"D Copolov","year":"1998","unstructured":"Copolov D, Bell W, Benson W, Keks N, Strazzeri D, Johnson G . Clozapine treatment in Australia: a review of haematological monitoring. Med J Aust 1998; 168: 495\u2013497.","journal-title":"Med J Aust"},{"key":"BF6500179_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF01064682","volume":"63","author":"J Lieberman","year":"1992","unstructured":"Lieberman J, Safferman AZ . Clinical profile of clozapine: adverse reactions and agranulocytosis. Psychiatr Q 1992; 63: 51\u201370.","journal-title":"Psychiatr Q"},{"key":"BF6500179_CR11","first-page":"139","volume":"55","author":"SL Gerson","year":"1994","unstructured":"Gerson SL . G-CSF and the management of clozapine-induced agranulocytosis. J Clin Psychiatry 1994; 55: 139\u2013142.","journal-title":"J Clin Psychiatry"},{"key":"BF6500179_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2165\/00023210-199707020-00005","volume":"2","author":"M Pirmohamed","year":"1997","unstructured":"Pirmohamed M, Park K . Mechanism of clozapine-induced agranulocytosis: current status of research and implications for drug development. CNS Drugs 1997; 2: 139\u2013158.","journal-title":"CNS Drugs"},{"key":"BF6500179_CR13","first-page":"1476","volume":"275","author":"ZC Liu","year":"1995","unstructured":"Liu ZC, Uetrecht JP . Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. J Pharmacol Exp Ther 1995; 275: 1476\u20131483.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF6500179_CR14","first-page":"999","volume":"53","author":"I Gardner","year":"1998","unstructured":"Gardner I, Leeder JS, Chin T, Zahid N, Uetrecht JP . A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo. Mol Pharmacol 1998; 53: 999\u20131008.","journal-title":"Mol Pharmacol"},{"key":"BF6500179_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/mol.58.1.207","volume":"58","author":"DP Williams","year":"2000","unstructured":"Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK . Induction of metabolism-dependent and \u2013independent neutrophil apoptosis by clozapine. Mol Pharmacol 2000; 58: 207\u2013216.","journal-title":"Mol Pharmacol"},{"key":"BF6500179_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1054\/mehy.1998.0734","volume":"53","author":"I Guest","year":"1999","unstructured":"Guest I, Uetrecht J . Drugs that induce neutropenia\/agranulocytosis may target specific components of the stromal cell extracellular matrix. Med Hypotheses 1999; 53: 145\u2013151.","journal-title":"Med Hypotheses"},{"key":"BF6500179_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2141.1994.tb04786.x","volume":"86","author":"SL Gerson","year":"1994","unstructured":"Gerson SL, Arce C, Meltzer HY . N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis. Br J Haematol 1994; 86: 555\u2013561.","journal-title":"Br J Haematol"},{"key":"BF6500179_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/03602539208996297","volume":"24","author":"JP Uetrecht","year":"1992","unstructured":"Uetrecht JP . The role of leukocyte-generated metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab Rev 1992; 24: 299\u2013366.","journal-title":"Drug Metab Rev"},{"key":"BF6500179_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/aja.1001870306","volume":"187","author":"K Yamazaki","year":"1990","unstructured":"Yamazaki K, Allen T . Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the \u2018neuro-reticular complex\u2019. Am J Anat 1990; 187: 261\u2013276.","journal-title":"Am J Anat"},{"key":"BF6500179_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1046\/j.1365-2141.2000.01808.x","volume":"108","author":"C Broome","year":"2000","unstructured":"Broome C, Whetton A, Miyan J . Neuropeptide control of bone marrow neutrophil production is mediated by both direct and indirect effects on CFU-GM. Br J Haematol 2000; 108: 140\u2013150.","journal-title":"Br J Haematol"},{"key":"BF6500179_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-2680.1999.00135.x","volume":"19","author":"F Amenta","year":"1999","unstructured":"Amenta F, Bronzetti E, Felici L, Ricci A, Tayebati S . Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study. J Auton Pharmacol 1999; 19: 151\u2013159.","journal-title":"J Auton Pharmacol"},{"key":"BF6500179_CR22","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1161\/01.HYP.30.6.1566","volume":"30","author":"A Ricci","year":"1997","unstructured":"Ricci A, Bronzetti E, Mulatero P, Schena M, Veglio F, Amenta F . Dopamine D3 receptor in peripheral mononuclear cells of essential hypertensives. Hypertension 1997; 30: 1566\u20131571.","journal-title":"Hypertension"},{"key":"BF6500179_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0165-5728(98)00207-0","volume":"92","author":"A Ricci","year":"1998","unstructured":"Ricci A, Bronzetti E, Felici L, Greco S, Amenta F . Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study. J Neuroimmunol 1998; 92: 191\u2013195.","journal-title":"J Neuroimmunol"},{"key":"BF6500179_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0304-3940(97)00413-8","volume":"229","author":"A Ricci","year":"1997","unstructured":"Ricci A, Bronzetti E, Felici L, Tayebati S, Amenta F . Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study. Neurosci Lett 1997; 229: 130\u2013134.","journal-title":"Neurosci Lett"},{"key":"BF6500179_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-5728(94)90057-4","volume":"53","author":"A Ricci","year":"1994","unstructured":"Ricci A, Amenta F . Dopamine D5 receptors in human peripheral blood lymphocytes: a radioligand binding study. J Neuroimmunol 1994; 53: 1\u20137.","journal-title":"J Neuroimmunol"},{"key":"BF6500179_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0304-3940(96)12567-2","volume":"208","author":"E Bronzetti","year":"1996","unstructured":"Bronzetti E, Adani O, Amenta F, Felici L, Mannino F, Ricci A . Muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. Neurosci Lett 1996; 208: 211\u2013215.","journal-title":"Neurosci Lett"},{"key":"BF6500179_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0165-5728(99)00119-8","volume":"99","author":"S Tayebati","year":"1999","unstructured":"Tayebati S, Codini M, Gallai V, Mannino F, Parnetti L, Ricci A et al. Radioligand binding assay of M1\u2013M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol 1999; 99: 224\u2013229.","journal-title":"J Neuroimmunol"},{"key":"BF6500179_CR28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/01.HYP.33.2.708","volume":"33","author":"A Ricci","year":"1999","unstructured":"Ricci A, Bronzetti E, Conterno A, Greco S, Mulatero P, Schena M et al. Alpha1-adrenergic receptor subtypes in human peripheral blood lymphocytes. Hypertension 1999; 33: 708\u2013712.","journal-title":"Hypertension"},{"key":"BF6500179_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-291X(84)90679-X","volume":"121","author":"S Titinchi","year":"1984","unstructured":"Titinchi S, Clark B . Alpha 2-adrenoceptors in human lymphocytes: direct characterisation by [3H]yohimbine binding. Biochem Biophys Res Commun 1984; 121: 1\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6500179_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ijc.2910490205","volume":"49","author":"J Goin","year":"1991","unstructured":"Goin J, Sterin-Borda L, Borda E, Finiasz M, Fernandez J, de Bracco M . Active alpha 2 and beta adrenoceptors in lymphocytes from patients with chronic lymphocytic leukemia. Int J Cancer 1991; 49: 178\u2013181.","journal-title":"Int J Cancer"},{"key":"BF6500179_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/0006-3223(95)00498-X","volume":"40","author":"J Vile","year":"1996","unstructured":"Vile J, Strange P . D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes. Biol Psychiatry 1996; 40: 881\u2013885.","journal-title":"Biol Psychiatry"},{"key":"BF6500179_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-5728(96)00148-8","volume":"71","author":"B Bondy","year":"1996","unstructured":"Bondy B, de Jonge S, Pander S, Primbs J, Ackenheil M . Identification of dopamine D4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction. J Neuroimmunol 1996; 71: 139\u2013144.","journal-title":"J Neuroimmunol"},{"key":"BF6500179_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0165-5728(99)00061-2","volume":"97","author":"U Bany","year":"1999","unstructured":"Bany U, Ryzewski J, Maslinski W . Relative amounts of mRNA encoding four subtypes of muscarinic receptors (m2\u2013m5) in human peripheral blood mononuclear cells. J Neuroimmunol 1999; 97: 191\u2013195.","journal-title":"J Neuroimmunol"},{"key":"BF6500179_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0165-5728(99)00042-9","volume":"96","author":"A Ricci","year":"1999","unstructured":"Ricci A, Bronzetti E, Mignini F, Tayebati S, Zaccheo D, Amenta F . Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol 1999; 96: 234\u2013240.","journal-title":"J Neuroimmunol"},{"key":"BF6500179_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1054\/mehy.1998.0734","volume":"53","author":"I Guest","year":"1999","unstructured":"Guest I, Uetrecht J . Drugs that induce neutropenia\/agranulocytosis may target specific components of the stromal cell extracellular matrix. Med Hypotheses 1999; 53: 145\u2013151.","journal-title":"Med Hypotheses"},{"key":"BF6500179_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3940(99)00259-1","volume":"266","author":"K Sato","year":"1999","unstructured":"Sato K, Fujii T, Watanabe Y, Yamada S, Ando T, Kazuko F et al. Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 1999; 266: 17\u201320.","journal-title":"Neurosci Lett"},{"key":"BF6500179_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1006\/bbrc.1993.1829","volume":"194","author":"Y Nagai","year":"1993","unstructured":"Nagai Y, Ueno S, Saeki Y, Soga F, Yanagihara T . Expression of the D3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem Biophys Res Commun 1993; 194: 368\u2013374.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6500179_CR38","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0039-6060(99)70171-6","volume":"126","author":"S Sookhai","year":"1999","unstructured":"Sookhai S, Wang J, McCourt M, O'Connell D, Redmond H . Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor- independent mechanism. Surgery 1999; 126: 314\u2013322.","journal-title":"Surgery"},{"key":"BF6500179_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0022-3956(96)00039-8","volume":"31","author":"S Sanyal","year":"1997","unstructured":"Sanyal S, Van Tol . Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action. J Psychiatr Res 1997; 31: 219\u2013232.","journal-title":"J Psychiatr Res"},{"key":"BF6500179_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ajmg.1320600611","volume":"60","author":"S Shaikh","year":"1995","unstructured":"Shaikh S, Collier D, Sham P, Pilowsky L, Sharma T, Lin L et al. Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients. Am J Med Genet 1995; 60: 541\u2013545.","journal-title":"Am J Med Genet"},{"key":"BF6500179_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0893-133X(96)00090-5","volume":"15","author":"M Rietschel","year":"1996","unstructured":"Rietschel M, Naber D, Oberlander H, Holzbach R, Fimmers R, Eggermann K et al. Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene. Neuropsychopharmacology 1996; 15: 491\u2013496.","journal-title":"Neuropsychopharmacology"},{"key":"BF6500179_CR42","first-page":"34","volume":"61","author":"A Egorova","year":"1998","unstructured":"Egorova A, Uspenskaia I, Kruglik O, Nefedova V, Ivanov V, Nefedov V . Disorder of the serotoninergic regulation of bone marrow cell proliferation under the action of a xenobiotic inducer of oxidative stress. Eksp Klin Farmakol 1998; 61: 34\u201337.","journal-title":"Eksp Klin Farmakol"},{"key":"BF6500179_CR43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4049\/jimmunol.137.1.276","volume":"137","author":"E Sternberg","year":"1986","unstructured":"Sternberg E, Trial J, Parker C . Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J Immunol 1986; 137: 276\u2013282.","journal-title":"J Immunol"},{"key":"BF6500179_CR44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/43.4.7897180","volume":"43","author":"S Hauser","year":"1995","unstructured":"Hauser S, Waldron J, Upuda K, Lipschitz D . Morphological characterization of stromal cell types in hematopoietically active long-term murine bone marrow cultures. J Histochem Cytochem 1995; 43: 371\u2013379.","journal-title":"J Histochem Cytochem"},{"key":"BF6500179_CR45","first-page":"313","volume":"22","author":"G Maestroni","year":"1994","unstructured":"Maestroni G, Conti A . Modulation of hematopoiesis via alpha 1-adrenergic receptors on bone marrow cells. Exp Hematol 1994; 22: 313\u2013320.","journal-title":"Exp Hematol"},{"key":"BF6500179_CR46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/blood.V86.2.531.bloodjournal862531","volume":"86","author":"S Corbel","year":"1995","unstructured":"Corbel S, Schneider E, Lemoine F, Dy M . Murine hematopoietic progenitors are capable of both histamine synthesis and uptake. Blood 1995; 86: 531\u2013539.","journal-title":"Blood"},{"key":"BF6500179_CR47","first-page":"132","volume":"111","author":"M Tan","year":"1998","unstructured":"Tan M, Pan Z, Wang Q, Xu Y . Effects of different subtypes of histamine receptors on proliferation and differentiation of murine colony forming unit granulocyte\u2013macrophage and colony forming unit megakaryocyte. Chin Med J (Engl) 1998; 111: 132\u2013135.","journal-title":"Chin Med J (Engl)"},{"key":"BF6500179_CR48","first-page":"625","volume":"41","author":"H Jenssen","year":"1982","unstructured":"Jenssen H, Eckert R, Mix E, Schulz U, Schnitzler S . Histamine-receptor bearing lymphocytes. II. The use of flow cytofluorometric analysis of histamine-receptors on mouse lymphocytes of different organs. Acta Biol Med Ger 1982; 41: 625\u2013633.","journal-title":"Acta Biol Med Ger"},{"key":"BF6500179_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF01782018","volume":"44","author":"T Ching","year":"1995","unstructured":"Ching T, Koelemij J, Bast A . The effect of histamine on the oxidative burst of HL60 cells before and after exposure to reactive oxygen species. Inflamm Res 1995; 44: 99\u2013104.","journal-title":"Inflamm Res"},{"key":"BF6500179_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1124\/mol.59.3.420","volume":"59","author":"C Liu","year":"2001","unstructured":"Liu C, Ma X, Jiang X, Wilson SJ, Hofstra CL, Blevitt J et al. Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol Pharmacol 2001; 59: 420\u2013426.","journal-title":"Mol Pharmacol"},{"key":"BF6500179_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0165-5728(96)00079-3","volume":"68","author":"E Hellstrom-Lindahl","year":"1996","unstructured":"Hellstrom-Lindahl E, Nordberg A . Muscarinic receptor subtypes in subpopulations of human blood mononuclear cells as analyzed by RT-PCR technique. J Neuroimmunol 1996; 68: 139\u2013144.","journal-title":"J Neuroimmunol"},{"key":"BF6500179_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1124\/mol.51.6.1007","volume":"51","author":"H Fujino","year":"1997","unstructured":"Fujino H, Kitamura Y, Yada T, Uehara T, Nomura Y . Stimulatory roles of muscarinic acetylcholine receptors on T cell antigen receptor\/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. Mol Pharmacol 1997; 51: 1007\u20131014.","journal-title":"Mol Pharmacol"},{"key":"BF6500179_CR53","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S0024-3205(98)00131-3","volume":"62","author":"K Kawashima","year":"1998","unstructured":"Kawashima K, Fujii T, Watanabe Y, Misawa H . Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes. Life Sci 1998; 62: 1701\u20131705.","journal-title":"Life Sci"},{"key":"BF6500179_CR54","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0140-6736(99)03111-6","volume":"354","author":"R Naumann","year":"1999","unstructured":"Naumann R, Felber W, Heilemann H, Reuster T . Olanzapine-induced agranulocytosis (letter). Lancet 1999; 354: 566\u2013567.","journal-title":"Lancet"},{"key":"BF6500179_CR55","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1034\/j.1600-0447.2001.00429.x","volume":"104","author":"HG Ruhe","year":"2001","unstructured":"Ruhe HG, Becker HE, Jessurun P, Marees CH, Heeringa M, Vermeulen HDB . Agranulocytosis and granulocytopenia associated with quetiapine. Acta Psychiatr Scand 2001; 104: 311\u2013313.","journal-title":"Acta Psychiatr Scand"},{"key":"BF6500179_CR56","first-page":"991","volume":"53","author":"I Gardner","year":"1998","unstructured":"Gardner I, Zahid N, MacCrimmon D, Uetrecht JP . A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes. Mol Pharmacol 1998; 53: 991\u2013998.","journal-title":"Mol Pharmacol"},{"key":"BF6500179_CR57","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1073\/pnas.77.8.4756","volume":"77","author":"S Gartner","year":"1980","unstructured":"Gartner S, Kaplan H . Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A 1980; 77: 4756\u20134759.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BF6500179_CR58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate\u2013phenol\u2013chloroform extraction. Anal Biochem 1987; 162: 156\u2013159.","journal-title":"Anal Biochem"},{"key":"BF6500179_CR59","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/342923a0","volume":"342","author":"B Giros","year":"1989","unstructured":"Giros B, Sokoloff P, Martres M, Riou J, Emorine L, Schwartz J . Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 1989; 342: 923\u2013926.","journal-title":"Nature"},{"key":"BF6500179_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/(SICI)1096-8628(19960216)67:1<63::AID-AJMG11>3.0.CO;2-N","volume":"67","author":"N Griffon","year":"1996","unstructured":"Griffon N, Crocq M, Pilon C, Martres M, Mayerova A, Uyanik G et al. Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am J Med Genet 1996; 67: 63\u201370.","journal-title":"Am J Med Genet"},{"key":"BF6500179_CR61","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1006\/geno.1996.0397","volume":"35","author":"E Xie","year":"1996","unstructured":"Xie E, Zhu L, Zhao L, Chang L . The human serotonin 5-HT2C receptor: complete cDNA, genomic structure, and alternatively spliced variant. Genomics 1996; 35: 551\u2013561.","journal-title":"Genomics"},{"key":"BF6500179_CR62","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1749-6632.1998.tb10196.x","volume":"15","author":"M Bruss","year":"1998","unstructured":"Bruss M, Gothert M, Hayer M, Bonisch H . Molecular cloning of alternatively spliced human 5-HT3 receptor cDNAs. Ann NY Acad Sci 1998; 15: 234\u2013235.","journal-title":"Ann NY Acad Sci"},{"key":"BF6500179_CR63","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1046\/j.1471-4159.1997.68041372.x","volume":"68","author":"DEA Heidmann","year":"1997","unstructured":"Heidmann DEA, Metcalf MA, Kohen R, Hamblin MW . Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron\u2013exon organization. J Neurochem 1997; 68: 1372\u20131381.","journal-title":"J Neurochem"},{"key":"BF6500179_CR64","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1471-4159.1994.63020465.x","volume":"63","author":"E Cook Jr","year":"1994","unstructured":"Cook Jr E, Fletcher K, Wainwright M, Marks N, Yan S, Leventhal B . Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor. J Neurochem 1994; 63: 465\u2013469.","journal-title":"J Neurochem"},{"key":"BF6500179_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1046\/j.1471-4159.1996.66010047.x","volume":"66","author":"R Kohen","year":"1996","unstructured":"Kohen R, Metcalf M, Khan N, Druck T, Huebner K, Lachowicz J et al. Cloning, characterization and chromosomal localization of a human 5- HT6 serotonin receptor. J Neurochem 1996; 66: 47\u201356.","journal-title":"J Neurochem"},{"key":"BF6500179_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0014-5793(98)00024-6","volume":"422","author":"D Chang","year":"1998","unstructured":"Chang D, Chang T, Yamanishi S, Salazar F, Kosaka A, Khare R et al. Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms. FEBS Lett 1998; 422: 279\u2013283.","journal-title":"FEBS Lett"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6500179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6500179","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6500179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:39:58Z","timestamp":1684413598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6500179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["BF6500179"],"URL":"https:\/\/doi.org\/10.1038\/sj.tpj.6500179","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}